Sculptra Aesthetic

DEVICE7 trials

Sponsors

Goldman, Butterwick, Fitzpatrick and Groff, Sadick Research Group, Galderma R&D, Erevna Innovations Inc.

Conditions

AestheticAgingBiostimulatorCelluliteFacial WrinklesHyaluronic AcidInjectablesLaxity; Skin

Phase 2

Assess Impact of Poly-L-lactic Acid on GLP1 Subjects

Not yet recruitingNCT07217743

Goldman, Butterwick, Fitzpatrick and GroffLaxity; Skin

Start: 2025-10-27End: 2026-10-31Target: 20Updated: 2025-10-16

Phase 4

PLLA and CaHA-R for Aesthetic Rejuvenation

RecruitingNCT07202117

Erevna Innovations Inc.Aesthetic

Start: 2025-11-01End: 2026-12-01Target: 45Updated: 2025-10-01

Post-Menopause Skin Rejuvenation Study

Active, not recruitingNCT07205744

Erevna Innovations Inc.Aesthetic, Biostimulator, Hyaluronic Acid +3

Start: 2025-08-14End: 2026-09-28Updated: 2026-01-22

Unknown Phase

Clinical Trial of Poly-L-lactic Acid (Sculptra Aesthetic) for the Treatment of Cellulite of the Buttocks and Thighs

Goldman, Butterwick, Fitzpatrick and GroffCellulite

Start: 2021-04-09End: 2022-06-01Target: 20Updated: 2021-04-12

Histology Study of Biostimulatory Activity of Injectable Poly-L-Lactic Acid (Sculptra Aesthetic)

Sadick Research GroupFacial Wrinkles, Nasolabial Fold

Start: 2021-08-09End: 2022-09-01Target: 10Updated: 2021-08-11

Sculptra Chart Review

CompletedNCT05463978

Galderma R&DNon-facial Skin Aesthetic Conditions

Start: 2022-07-14End: 2022-10-14Updated: 2022-10-24

Safety and Efficacy of Injectable Poly-L-Lactic Acid for Volume Loss in the Temples Using Dual Plane Injections

Sadick Research GroupAging, Lipoatrophy

Start: 2022-11-30End: 2023-11-30Target: 20Updated: 2022-11-08